 |
|
Catamenial Insulin Reactions Treated With a Long-Acting Gonadotropin Releasing Hormone Agonist
Gerard S. Letterie, MD;
Paul N. Fredlund, MD
Arch Intern Med. 1994;154(16):1868-1870.
Abstract
Exacerbation of a variety of symptoms during the menstrual cycle is a well-described phenomenon. The exact causes of these changes are poorly understood, and no specific and efficacious therapy has been described. We successfully treated a patient with severe catamenial insulin reactions with a long-acting gonadotropin releasing hormone agonist to suppress menstrual function and added a combination of estrogen and progestin to offset any adverse effect of the resultant hypoestrogenemia for 1 year.
(Arch Intern Med. 1994;154:1868-1870)
Author Affiliations
From the Reproductive Endocrinology Service, Department of Obstetrics and Gynecology (Dr Letterie) and the Medical Endocrinology Service, Department of Medicine (Dr Fredlund), Virginia Mason Medical Center, Seattle, Wash.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
INSULIN RESISTANCE AS AN ADVERSE EFFECT OF LEUPROLIDE AND BICALUTAMIDE TREATMENT
Paniagua and Hirsch
J Gerontol A Biol Sci Med Sci 2005;60:1283-1284.
FULL TEXT
Effects of the Menstrual Cycle on Medical Disorders
Case and Reid
Arch Intern Med 1998;158:1405-1412.
ABSTRACT
| FULL TEXT
|
